Moreover, GLR reduces the ACE2 mRNA expression of lung cells in vitro.340 These encouraging evidences suggest that HMGB1 inhibitors are similarly promising drug candidates for the treatment of patients with COVID-19. The gene discussed is HMGB1; the disease is COVID-19.